or individuals living with rare and ultra-rare genetic disorders, finding an accurate diagnosis and obtaining life-saving treatment can feel like an uphill battle. Globally, patients often navigate a multi-year "diagnostic odyssey," moving between specialists while waiting for viable therapeutic options. In niche biopharmaceutical markets, commercializing specialized treatments presents unique...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)